The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
New microRNA-based diagnostic test for lung cancer classification.
Ranit Aharonov
Employment or Leadership Position - Rosetta Genomics
Stock Ownership - Rosetta Genomics
Gila Lithwick Yanai
Employment or Leadership Position - Rosetta Genomics
Stock Ownership - Rosetta Genomics
Hila Benjamin
Employment or Leadership Position - Rosetta Genomics
Stock Ownership - Rosetta Genomics
Mats Olot Sanden
Employment or Leadership Position - Rosetta Genomics (U)
Stock Ownership - Rosetta Genomics
Marluce Bibbo
Research Funding - Rosetta Genomics
Craig Thurm
Research Funding - Rosetta Genomics
Laurie Horowitz
Research Funding - Rosetta Genomics
Yajue Huang
Research Funding - Rosetta Genomics
Meora Feinmesser
Research Funding - Rosetta Genomics
Iris Barshack
Research Funding - Rosetta Genomics
Steve j Hou
Research Funding - Rosetta Genomics
Tina B Edmonston
No relevant relationships to disclose
Karin Ashkenazi
Employment or Leadership Position - Rosetta Genomics
Stock Ownership - Rosetta Genomics